Mechanism and inhibition of cytochrome P-450 aromatase
How does that impact people that do need it
Wegovy has been FDA-approved since June 2021 for chronic weight management in adults with a BMI of 30 or above, or 27 and above with a weight-related comorbidity
Other Factors That May Affect Urination During GLP-1 Therapy Several concurrent factors may influence urinary patterns in patients taking GLP-1 medications, and it is important to consider these when evaluating symptoms: Concomitant medications : Many patients on GLP-1 therapy take other medications that affect urination
Blood sugar regulation: Semaglutide and Tirzepatide improve blood sugar control by enhancing insulin secretion and sensitivity
Because semaglutide is a complex synthetic product, Health Canada requires manufacturers to demonstrate that generic versions match the brand-name drug in safety, efficacy, and quality, without differences that could impact these factors